Get started
Author

Josefin Snellman

Observed names: J Snellman, J. Snellman, Snellman, Josefin
ORCID: 0009-0003-6634-3823
Observed ORCID: 0009-0003-6634-3823
OpenAlex ID: A5017296870
Acute destruction of the synaptic ribbon reveals a role for the ribbon in vesicle priming
2011 · Josefin Snellman, Bhupesh Mehta, et al. · Nature Neuroscience · 156
Effect of Vasoactive Intestinal Polypeptide on Development of Migraine Headaches
2021 · Lanfranco Pellesi, Mohammad Al-Mahdi Al-Karagholi, et al. · JAMA Network Open · 81
PDF
Synaptic Ribbons Influence the Size and Frequency of Miniature-like Evoked Postsynaptic Currents
2013 · Bhupesh Mehta, Josefin Snellman, et al. · Neuron · 79
PDF
Regulation of ON bipolar cell activity
2008 · Josefin Snellman, Tejinder Kaur, et al. · Progress in Retinal and Eye Research · 74
cGMP-Dependent Kinase Regulates Response Sensitivity of the Mouse On Bipolar Cell
2004 · Josefin Snellman, Scott Nawy · Journal of Neuroscience · 72
PDF
Opening of BKCa channels causes migraine attacks: a new downstream target for the treatment of migraine
2021 · Mohammad Al-Mahdi Al-Karagholi, Hashmat Ghanizada, et al. · Pain · 66
Real-world long-term efficacy and safety of erenumab in adults with chronic migraine: a 52-week, single-center, prospective, observational study
2022 · Christopher Kjaer Cullum, Thien Phu Do, et al. · The Journal of Headache and Pain · 62
PDF
Two-hour infusion of vasoactive intestinal polypeptide induces delayed headache and extracranial vasodilation in healthy volunteers
2020 · Lanfranco Pellesi, Mohammad Al-Mahdi Al-Karagholi, et al. · Cephalalgia · 53
Switching between transient and sustained signalling at the rod bipolar‐AII amacrine cell synapse of the mouse retina
2009 · Josefin Snellman, David Zenisek, et al. · The Journal of Physiology · 48
Burden of Migraine in Patients With Preventive Treatment Failure Attending European Headache Specialist Centers: Real-World Evidence From the BECOME Study
2021 · Patricia Pozo-Rosich, Christian Lucas, et al. · Pain and Therapy · 45
PDF
Characterisation of vasodilatory responses in the presence of the CGRP receptor antibody erenumab in human isolated arteries
2019 · Eloísa Rubio-Beltrán, Alejandro Labastida-Ramírez, et al. · Cephalalgia · 39
PDF
Erenumab (AMG 334), a monoclonal antagonist antibody against the canonical CGRP receptor, does not impair vasodilatory or contractile responses to other vasoactive agents in human isolated cranial arteries
2019 · Lena Ohlsson, Kristian A Haanes, et al. · Cephalalgia · 38
Early Use of Erenumab vs Nonspecific Oral Migraine Preventives
2024 · Patricia Pozo-Rosich, David Dolezil, et al. · JAMA Neurology · 37
PDF
Hypersensitivity to calcitonin gene-related peptide in chronic migraine
2020 · Afrim Iljazi, Håkan Ashina, et al. · Cephalalgia · 36
Erenumab for Treatment of Persistent Erythema and Flushing in Rosacea
2024 · Nita K. F. Wienholtz, Casper E. Christensen, et al. · JAMA Dermatology · 33
Second messenger signalling bypasses CGRP receptor blockade to provoke migraine attacks in humans
2023 · Thien Phu Do, Christina Deligianni, et al. · Brain · 32
PDF
Regulation of the Retinal Bipolar Cell mGluR6 Pathway by Calcineurin
2002 · Josefin Snellman, Scott Nawy · Journal of Neurophysiology · 31
Opening of BK Ca channels alters cerebral hemodynamic and causes headache in healthy volunteers
2020 · Mohammad Al-Mahdi Al-Karagholi, Hashmat Ghanizada, et al. · Cephalalgia · 30
Safety and tolerability of erenumab in individuals with episodic or chronic migraine across age groups: a pooled analysis of placebo-controlled trials
2022 · Christian Lampl, Viktoria Kraus, et al. · The Journal of Headache and Pain · 20
PDF
Activation of ATP-sensitive potassium channels triggers migraine attacks independent of calcitonin gene-related peptide receptors: a randomized placebo-controlled trial
2024 · Bianca Raffaelli, Thien Phu Do, et al. · Cephalalgia · 14
Induction of cGMP-mediated migraine attacks is independent of CGRP receptor activation
2024 · Bianca Raffaelli, Thien Phu Do, et al. · Cephalalgia · 11
Plasma Levels of CGRP During a 2-h Infusion of VIP in Healthy Volunteers and Patients With Migraine: An Exploratory Study
2022 · Lanfranco Pellesi, Mohammad Al-Mahdi Al-Karagholi, et al. · Frontiers in Neurology · 11
Pharmacology of erenumab in human isolated coronary and meningeal arteries: Additional effect of gepants on top of a maximum effect of erenumab
2024 · Tessa de Vries, Eloísa Rubio‐Beltrán, et al. · British Journal of Pharmacology · 10
PDF
Post hoc analysis of clinical trial data and pharmacokinetic data to assess wearing‐off of erenumab within monthly treatment cycle
2022 · David W. Dodick, Andrew M. Blumenfeld, et al. · Headache The Journal of Head and Face Pain · 8
PDF
Prevalence and Burden of Migraine in Switzerland: Cross-Sectional Study in ten Specialised Headache Centres from the BECOME Study
2023 · Reto Agosti, Catherine Parzini, et al. · Pain and Therapy · 6
PDF
Works count: 63
Citation count: 1,113
H-index: 19
I10-index: 23
Year
Topic
Type